Gene · 4303
Papers2,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated bioinformatics analysis, machine learning, and experimental validation reveal that ACSL1 drives myocardial ischemia reperfusion injury via ferroptosis. | J Bioenerg Biomembr | 2026 | 42782425 | PubTator, text mining | PubMed |
| OGT-rearranged mesenchymal neoplasm of the palm with a novel C3orf62/MAPS partner gene: expanding the molecular spectrum of this rare entity. | Virchows Arch | 2026 | 42734649 | PubTator, text mining | PubMed |
| FOXO6 as a Transcriptional Regulator of Hepatic Metabolic Inflammation and Hepatocarcinogenesis. | IUBMB Life | 2026 | 42665991 | PubTator, text mining | PubMed |
| Using the simple telegraph model to decipher transcriptional burst regulation across genome-wide data. | iScience | 2026 | 42620746 | PubTator, text mining | PubMed |
| FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy. | Kidney Res Clin Pract | 2026 | 42619388 | PubTator, text mining | PubMed |
| Contrasting Effects of HT-2 Toxin Exposure and ZIP6 Knockdown on Chondrocyte Extracellular Matrix Metabolism. | J Biochem Mol Toxicol | 2026 | 42533448 | PubTator, text mining | PubMed |
| FOXO4 as a Redox-Sensitive Regulator of Antioxidant Defense and Cellular Senescence: Cysteine-Based Signaling, p53 Interaction, and Therapeutic Targeting. | Antioxidants (Basel) | 2026 | 42510573 | PubTator, text mining | PubMed |
| NMR investigation of conformational heterogeneity in FOXO4 CR2C binding to the MLL site of CBP KIX. | J Magn Reson | 2026 | 42472485 | PubTator, text mining | PubMed |
| Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways. | Aging Adv | 2026 | 42370305 | PubTator, text mining | PubMed |
| FOXO family and neurodegenerative diseases: Mechanisms of action and therapeutic potential. | Redox Biol | 2026 | 42202637 | PubTator, text mining | PubMed |
| Transcriptional Control by FOXO4 Regulates Trophoblast Differentiation and Safeguards Placental Development Through MITD1- and PCBP2-Mediated Redox Homeostasis. | FASEB J | 2026 | 42201761 | PubTator, text mining | PubMed |
| FOXO transcription factors in Alzheimer's Disease: balancing neuroprotection and neuronal degeneration. | Mol Biol Rep | 2026 | 42189322 | PubTator, text mining | PubMed |
| NMR and biophysical investigation of selective recognition of FOXO4 CR3 by CBP TAZ1 domain. | Biophys Chem | 2026 | 42107395 | PubTator, text mining | PubMed |
| FOXO1-mediated cell cycle arrest enhances osteogenic differentiation of spheroid-cultured human periodontal ligament-derived multipotent mesenchymal stromal cells. | Regen Ther | 2026 | 42099746 | PubTator, text mining | PubMed |
| Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer. | BMC Genom Data | 2026 | 42098607 | PubTator, text mining | PubMed |
| PKCβ II antagonizes O-GlcNAcylated FOXO4 and inhibits lipid synthesis. | Apoptosis | 2026 | 42096129 | PubTator, text mining | PubMed |
| Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42024235 | PubTator, text mining | PubMed |
| CHK2-USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis. | Proc Natl Acad Sci U S A | 2026 | 41980094 | PubTator, text mining | PubMed |
| MiR-142-3p promotes radioresistance by targeting FOXO4 in colorectal cancer. | Biol Direct | 2026 | 41933410 | PubTator, text mining | PubMed |
| FOXO1 transcription factor modulates airway epithelial responses to viral infection. | PLoS One | 2026 | 41931532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4303/papers